Chlamydia Trachomatis Pathogenesis and Host Interactions

Chlamydia trachomatis is a leading cause of bacterial sexually transmitted infections and ocular disease worldwide. This obligate intracellular bacterium follows a unique biphasic developmental cycle within epithelial cells, alternating between infectious elementary bodies and metabolically active reticulate bodies. Upon adhesion to host mucosal surfaces, C. trachomatis invades via receptor-mediated uptake and resides within a specialised membrane compartment termed the inclusion. Within this niche, the pathogen co-opts host lipid and vesicular trafficking pathways to acquire nutrients and establish a replicative habitat. Secretion of type III effector proteins remodels cytoskeletal architecture and modulates cell-cycle pathways, sometimes inducing centrosome amplification and perturbing cytokinesis. The major outer membrane protein (MOMP) and other surface antigens initiate host immune recognition, but the bacterium often evades clearance through subversion of innate signalling and by dampening apoptosis. Persistent infection may drive chronic inflammation, contributing to pelvic inflammatory disease, infertility and, in ocular trachoma, scarring and blindness. Genome evolution studies have revealed gene-gain events that facilitated adaptation to an intracellular lifestyle, underscoring the metabolic versatility of this lineage. Advances in vaccine research have demonstrated that eliciting a robust Th1/Th17 immune profile and neutralising antibodies against conserved epitopes can confer durable protection in preclinical models, charting a course towards effective prophylaxis.

Research from Nature Portfolio

Recent studies have reconstructed the evolutionary trajectory of chlamydial genomes, revealing substantial gene acquisition that underpinned the transition to an endosymbiotic lifestyle. Contrary to the expectation of reductive genome streamlining, metabolic and respiratory genes characteristic of protist-infecting lineages were gained, indicating an early capacity for facultative anaerobiosis. Parallel work in vaccine immunology has shown that a candidate formulation combining a multi-serovar MOMP-derived antigen with a Th1/Th17-promoting adjuvant elicits comparable cellular and antibody responses in mice and humans. This vaccine induced long-lived T cell epitopes conserved across serovars and afforded durable protection against ascending genital infection in animal models, highlighting immune correlates to guide human trials.

Chlamydia Trachomatis Pathogenesis and Host Interactions publication trend

The graph below shows the total number of articles in chlamydia trachomatis pathogenesis and host interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Elementary body (EB): The infectious, extracellular form of C. trachomatis that initiates host cell infection.

Reticulate body (RB): The replicative, non-infectious form that subdivides within the inclusion.

Inclusion: A membrane-bound vacuole formed post-invasion, serving as the intracellular niche for chlamydial development.

Type III secretion system (T3SS): A specialised bacterial apparatus that translocates effector proteins into host cells to manipulate cellular processes.

Major Outer Membrane Protein (MOMP): The dominant surface antigen of C. trachomatis, critical for adherence and immune recognition.

Th1/Th17 cytokine profile: An immune signature characterised by interferon-γ and interleukin-17 secretion, associated with protective responses against intracellular pathogens.

References

1. Gene gain facilitated endosymbiotic evolution of Chlamydiae. Nature Microbiology (2023).
2. Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature Communications (2024).
3. Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination. EBioMedicine (2024).
4. The Chlamydia trachomatis type III-secreted effector protein CteG induces centrosome amplification through interactions with centrin-2. Proceedings of the National Academy of Sciences of the United States of America (2023).